• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

The Dawning of a New Horizon for Venous Leg Ulcer Treatment


Wound masterclass – Vol 2 – March 2023

Editorial Summary

A high percentage of patients present with chronic or recurrent venous leg ulcers that are associated with a reduction in health-related quality of life and an increased economic burden to healthcare systems. The current challenge of generating high quality evidence for potential treatments is detrimental to patient outcomes. Implementing a self-controlled trial design in addition to using more achievable trial endpoints may provide a solution to the current lack of evidence. Furthermore, the use of a neuromuscular electrical stimulator as well as standard wound care may improve ulcer management. This article provides an overview of a study implementing a randomised self-controlled study design to assess the efficacy of a wearable device neuromuscular electrostimulator.